Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
-
221
-
222
-
223
Univariate and multivariate analysis of variables associated with good and poor responders to TFESI.
Published 2025Subjects: -
224
-
225
The serum concentrations of cytokines between good responders and poor responders to TFESI.
Published 2025Subjects: -
226
Demographic data and baseline characteristics between good and poor responders to TFESI.
Published 2025Subjects: -
227
-
228
-
229
Comparison of questionnaire scores among genotypes for the significant associations.
Published 2025Subjects: -
230
-
231
-
232
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Animal studies demonstrated that inotodiol possessed the ability to suppress tumor growth in nude mice models, at the same time, there was no significant impact on the body weight and organs of the mice. …”
-
233
-
234
-
235
-
236
-
237
-
238
-
239
Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.
Published 2025“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”
-
240